Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure
Authors
Keywords
-
Journal
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Canadian Science Publishing
Online
2023-09-26
DOI
10.1139/cjpp-2023-0226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II
- (2023) Keisuke Okuno et al. HYPERTENSION
- The mechanism of low-level arsenic exposure-induced hypertension: Inhibition of the activity of the angiotensin-converting enzyme 2
- (2023) Md. Shiblur Rahaman et al. CHEMOSPHERE
- Angiotensin-converting enzyme inhibitory peptide attenuates cardiac hypertrophy associated with ACE2/Ang (1–7)/MasR axis and PKCβ1 pathway
- (2023) Rui Ge et al. Journal of Functional Foods
- Atrial Electrical Remodeling in Mice With Cardiac‐Specific Overexpression of Angiotensin II Type 1 Receptor
- (2022) Julie Demers et al. Journal of the American Heart Association
- Effect of the Renin-Angiotensin System Inhibitors on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials
- (2022) Kamal Awad et al. MAYO CLINIC PROCEEDINGS
- Walnut supplementation after fructose-rich diet is associated with a beneficial fatty acid ratio and increased ACE2 expression in the rat heart
- (2022) Maja Bošković et al. Frontiers in Physiology
- Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy
- (2022) Sukhwinder K. Bhullar et al. Cells
- Sustained AT1R stimulation induces upregulation of growth factors in human cardiac fibroblasts via Gαq/TGF-β/ERK signaling that influences myocyte hypertrophy
- (2022) Ratchanee Duangrat et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice
- (2022) Yan Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Extracellular vesicles DJ-1 derived from hypoxia-conditioned hMSCs alleviate cardiac hypertrophy by suppressing mitochondria dysfunction and preventing ATRAP degradation
- (2022) Yao Lu et al. PHARMACOLOGICAL RESEARCH
- Novel Interactions Involving the Mas Receptor Show Potential of the Renin–Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia
- (2021) Rafael Rivas-Santisteban et al. Neurotherapeutics
- Anti-diarrheal therapeutic potential of Diminazene Aceturate stimulation of the ACE II/Ang-(1-7)/Mas receptor axis in mice: a trial study
- (2021) Luan K.M. Souza et al. BIOCHEMICAL PHARMACOLOGY
- Direct Actions of AT 1 (Type 1 Angiotensin) Receptors in Cardiomyocytes Do Not Contribute to Cardiac Hypertrophy
- (2021) Matthew A. Sparks et al. HYPERTENSION
- Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system
- (2021) Michal Herman-Edelstein et al. Cardiovascular Diabetology
- The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling
- (2021) Michaela Adamcova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- RAAS, ACE2 and COVID-19; a mechanistic review
- (2021) Ahmed Elshafei et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure
- (2021) Anureet K. Shah et al. Antioxidants
- p47phox-Dependent Oxidant Signalling through ASK1, MKK3/6 and MAPKs in Angiotensin II-Induced Cardiac Hypertrophy and Apoptosis
- (2021) Fangfei Liu et al. Antioxidants
- SARS-COV-2 in type 2 diabetic patients: Possible roles of exercise training as a medicine
- (2021) Mehdi Kushkestani et al. CURRENT DIABETES REVIEWS
- Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension
- (2021) Giovanna Castoldi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy
- (2021) Lingli Xie et al. Frontiers in Endocrinology
- Recent Research Advances in Renin-Angiotensin-Aldosterone System Receptors
- (2020) Kengo Azushima et al. CURRENT HYPERTENSION REPORTS
- The Vasoactive Mas Receptor in Essential Hypertension
- (2020) Amalie L. Povlsen et al. Journal of Clinical Medicine
- Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway
- (2020) Youming Chen et al. Aging-US
- ACE2, COVID-19, and ACE Inhibitor and ARB Use during the Pandemic: The Pediatric Perspective
- (2020) Andrew M. South et al. HYPERTENSION
- BMAL1 regulates mitochondrial fission and mitophagy through mitochondrial protein BNIP3 and is critical in the development of dilated cardiomyopathy
- (2020) Ermin Li et al. Protein & Cell
- Stretch-Induced Biased Signaling in Angiotensin II Type 1 and Apelin Receptors for the Mediation of Cardiac Contractility and Hypertrophy
- (2020) Kinya Seo et al. Frontiers in Physiology
- Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
- (2020) Silvana Vasile et al. Biomolecules
- Distinct roles of calmodulin and Ca2+/calmodulin-dependent protein kinase II in isopreterenol-induced cardiac hypertrophy
- (2020) Siqi Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- ACE2, Much More Than Just a Receptor for SARS-COV-2
- (2020) Lobelia Samavati et al. Frontiers in Cellular and Infection Microbiology
- Angiotensin Receptors Heterodimerization and Trafficking: How Much Do They Influence Their Biological Function?
- (2020) Natalia L. Rukavina Mikusic et al. Frontiers in Pharmacology
- ACE2, Metformin, and COVID-19
- (2020) Atul Malhotra et al. iScience
- Molecular biomarkers in cardiac hypertrophy
- (2019) Liu Zhu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Angiotensin Type 1 Receptor Blockers in Heart Failure
- (2019) Khuraijam Dhanachandra Singh et al. CURRENT DRUG TARGETS
- Nuclear G-protein-coupled receptors as putative novel pharmacological targets
- (2019) Rita Ribeiro-Oliveira et al. DRUG DISCOVERY TODAY
- Counter-regulatory renin–angiotensin system in cardiovascular disease
- (2019) Maria Paz Ocaranza et al. Nature Reviews Cardiology
- Unlocking the Secrets of Mitochondria in the Cardiovascular System
- (2019) Rong Tian et al. CIRCULATION
- Mechanisms for the transition from physiological to pathological cardiac hypertrophy
- (2019) Christopher J. Oldfield et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes
- (2018) Itamar Couto Guedes de Jesus et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Novel mechanisms of G-protein-coupled receptors functions: AT 1 angiotensin receptor acts as a signaling hub and focal point of receptor cross-talk
- (2018) András D. Tóth et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification of protein phosphatase involvement in the AT 2 receptor-induced activation of endothelial nitric oxide synthase
- (2018) A. Augusto Peluso et al. CLINICAL SCIENCE
- Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders
- (2018) Ewa Szczepanska-Sadowska et al. CURRENT HYPERTENSION REPORTS
- Novel Role for the Immunoproteasome Subunit PSMB10 in Angiotensin II–Induced Atrial Fibrillation in MiceNovelty and Significance
- (2018) Jing Li et al. HYPERTENSION
- Mechanisms of physiological and pathological cardiac hypertrophy
- (2018) Michinari Nakamura et al. Nature Reviews Cardiology
- Critical role of angiotensin II type 2 receptors in the control of mitochondrial and cardiac function in angiotensin II-preconditioned rat hearts
- (2018) Rebeca E. Nuñez et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
- (2018) Steven J. Forrester et al. PHYSIOLOGICAL REVIEWS
- The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)
- (2018) Robson Augusto Souza Santos et al. PHYSIOLOGICAL REVIEWS
- Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases
- (2018) Maria Angela Incalza et al. VASCULAR PHARMACOLOGY
- Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats
- (2018) Giovanna Castoldi et al. ACTA DIABETOLOGICA
- Therapeutic Targeting of Endosomal G-Protein-Coupled Receptors
- (2018) Alex R.B. Thomsen et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Anti-hypersensitive effect of angiotensin (1-7) on streptozotocin-induced diabetic neuropathic pain in mice
- (2018) Yoshiki Ogata et al. EUROPEAN JOURNAL OF PAIN
- Myocardial hypertrophy induced by high salt consumption is prevented by angiotensin II AT2 receptor agonist
- (2018) E.P.B. Dopona et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload
- (2018) Chen Chen et al. Redox Biology
- CD38 promotes angiotensin II-induced cardiac hypertrophy
- (2017) Xiao-Hui Guan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- AT2 receptors in cardiovascular and renal diseases
- (2017) Elena Kaschina et al. PHARMACOLOGICAL RESEARCH
- AT1 receptor signaling pathways in the cardiovascular system
- (2017) Tatsuo Kawai et al. PHARMACOLOGICAL RESEARCH
- Centrally Mediated Cardiovascular Actions of the Angiotensin II Type 2 Receptor
- (2017) U. Muscha Steckelings et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy
- (2017) Larissa B. Teixeira et al. Scientific Reports
- Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis
- (2016) G. E. Callera et al. BIOSCIENCE REPORTS
- Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart Failure
- (2016) Vaibhav B. Patel et al. CIRCULATION RESEARCH
- Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease
- (2016) B. S. M. Chow et al. CLINICAL SCIENCE
- c-Src Inhibition Improves Cardiovascular Function but not Remodeling or Fibrosis in Angiotensin II–Induced HypertensionNovelty and Significance
- (2016) Glaucia E. Callera et al. HYPERTENSION
- G-Protein–Coupled Receptor MrgD Is a Receptor for Angiotensin-(1–7) Involving Adenylyl Cyclase, cAMP, and Phosphokinase ANovelty and Significance
- (2016) Anja Tetzner et al. HYPERTENSION
- Physiological and pathological cardiac hypertrophy
- (2016) Ippei Shimizu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Angiotensin II type-1 receptor (AT1R) regulates expansion, differentiation, and functional capacity of antigen-specific CD8+ T cells
- (2016) João Luiz Silva-Filho et al. Scientific Reports
- Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
- (2015) Yow Keat Tham et al. ARCHIVES OF TOXICOLOGY
- Comparison of angiotensin-(1–7), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice
- (2015) Jianmin Yang et al. ATHEROSCLEROSIS
- Hypertension: Renin-Angiotensin-Aldosterone System Alterations
- (2015) L. te Riet et al. CIRCULATION RESEARCH
- Angiotensin type 2 receptors: blood pressure regulation and end organ damage
- (2015) Colin Sumners et al. CURRENT OPINION IN PHARMACOLOGY
- Stimulation of the Angiotensin II AT2 Receptor is Anti-inflammatory in Human Lipopolysaccharide-Activated Monocytic Cells
- (2015) Mario Menk et al. INFLAMMATION
- Pleiotropic Effects of Angiotensin II Receptor Signaling in Cardiovascular Homeostasis and Aging
- (2015) Takehiro Kamo et al. International Heart Journal
- AT2 Receptor Activities and Pathophysiological Implications
- (2015) Luis C. Matavelli et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP
- (2015) Nan Li et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- From Contractile Enhancement to Pathological Hypertrophy
- (2015) Tetsuro Ago et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Chronic angiotensin AT2R activation prevents high-fat diet-induced adiposity and obesity in female mice independent of estrogen
- (2015) Sourashish Nag et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Angiotensin-(1–7) and angiotensin-(1–9): function in cardiac and vascular remodelling
- (2014) Clare A. McKinney et al. CLINICAL SCIENCE
- Recent insights and therapeutic perspectives of angiotensin-(1–9) in the cardiovascular system
- (2014) Maria Paz Ocaranza et al. CLINICAL SCIENCE
- Angiotensin II and Vascular Injury
- (2014) Augusto C. Montezano et al. CURRENT HYPERTENSION REPORTS
- Angiotensin 1–7 Reduces Mortality and Rupture of Intracranial Aneurysms in Mice
- (2014) Ricardo A. Peña Silva et al. HYPERTENSION
- Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria
- (2014) Jessica Soto Hernández et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Redox regulation of cardiac hypertrophy
- (2014) Can M. Sag et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Mitochondrial reactive oxygen species production and respiratory complex activity in rats with pressure overload-induced heart failure
- (2014) Michael Schwarzer et al. JOURNAL OF PHYSIOLOGY-LONDON
- Efeitos cardiovasculares do receptor tipo 2da angiotensina
- (2014) Gabriel Faria-Costa et al. Revista Portuguesa de Cardiologia
- Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension
- (2013) David B. Matchar et al. ANNALS OF INTERNAL MEDICINE
- ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
- (2013) AC Simões e Silva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension
- (2013) Hiromichi Wakui et al. CARDIOVASCULAR RESEARCH
- The Discovery of the ACE2 Gene
- (2013) A.J. Marian CIRCULATION RESEARCH
- Discovery and Characterization of Alamandine
- (2013) Roberto Queiroga Lautner et al. CIRCULATION RESEARCH
- Angiotensin II type 1 receptor blockade restores angiotensin-(1–7)-induced coronary vasodilation in hypertrophic rat hearts
- (2013) Álvaro P. S. Souza et al. CLINICAL SCIENCE
- Redox signaling in cardiovascular health and disease
- (2013) Nageswara R. Madamanchi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Angiotensin-(1–7) in the Rostral Ventrolateral Medulla Modulates Enhanced Cardiac Sympathetic Afferent Reflex and Sympathetic Activation in Renovascular Hypertensive Rats
- (2013) Peng Li et al. HYPERTENSION
- Angiotensin Type 2 Receptor Stimulation Ameliorates Left Ventricular Fibrosis and Dysfunction via Regulation of Tissue Inhibitor of Matrix Metalloproteinase 1/Matrix Metalloproteinase 9 Axis and Transforming Growth Factor β1 in the Rat Heart
- (2013) Dilyara Lauer et al. HYPERTENSION
- Signaling effectors underlying pathologic growth and remodeling of the heart
- (2013) Jop H. van Berlo et al. JOURNAL OF CLINICAL INVESTIGATION
- Impact of the renin–angiotensin system on cardiac energy metabolism in heart failure
- (2013) Jun Mori et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo
- (2013) F. Billia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GPCR biased ligands as novel heart failure therapeutics
- (2013) Jonathan D. Violin et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature
- (2012) Aurelie Nguyen Dinh Cat et al. ANTIOXIDANTS & REDOX SIGNALING
- Redox Signaling in Cardiac Physiology and Pathology
- (2012) Joseph R. Burgoyne et al. CIRCULATION RESEARCH
- Angiotensin-(1–7): beyond the cardio-renal actions
- (2012) Danielle G. Passos-Silva et al. CLINICAL SCIENCE
- Agonist-Independent Constitutive Activity of Angiotensin II Receptor Promotes Cardiac Remodeling in Mice
- (2012) Noritaka Yasuda et al. HYPERTENSION
- Direct Angiotensin II Type 2 Receptor Stimulation in N ω -Nitro- l -Arginine-Methyl Ester–Induced Hypertension
- (2012) Ludovit Paulis et al. HYPERTENSION
- Mitochondrial function in cardiac hypertrophy
- (2012) Lu-Yu Zhou et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- In Vivo Expression of Angiotensin-(1-7) Lowers Blood Pressure and Improves Baroreflex Function in Transgenic (mRen2)27 Rats
- (2012) Maria A. Garcia-Espinosa et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: new players of the renin–angiotensin system
- (2012) Robson A S Santos et al. JOURNAL OF ENDOCRINOLOGY
- New therapeutic pathways in the RAS
- (2012) Michael Bader et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Superoxide anions modulate the effects of angiotensin-(1–7) in the rostral ventrolateral medulla on cardiac sympathetic afferent reflex and sympathetic activity in rats
- (2012) P. Li et al. NEUROSCIENCE
- AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function
- (2012) Shetal H. Padia et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- ACE2, angiotensin-(1–7), and Mas: the other side of the coin
- (2012) Michael Bader PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Regression of pathological cardiac hypertrophy: Signaling pathways and therapeutic targets
- (2012) Jianglong Hou et al. PHARMACOLOGY & THERAPEUTICS
- Promyelocytic Leukemia Zinc Finger Protein Activates GATA4 Transcription and Mediates Cardiac Hypertrophic Signaling from Angiotensin II Receptor 2
- (2012) Ning Wang et al. PLoS One
- Adenoviral Delivery of Angiotensin-(1-7) or Angiotensin-(1-9) Inhibits Cardiomyocyte Hypertrophy via the Mas or Angiotensin Type 2 Receptor
- (2012) Monica Flores-Muñoz et al. PLoS One
- Pressure overload-induced mild cardiac hypertrophy reduces left ventricular transmural differences in mitochondrial respiratory chain activity and increases oxidative stress
- (2012) Michel Kindo et al. Frontiers in Physiology
- Angiotensin-(1-7)-Mediated Signaling in Cardiomyocytes
- (2012) Enéas R. M. Gomes et al. International Journal of Hypertension
- ROS-induced ROS release in vascular biology: redox-redox signaling
- (2011) Natalya S. Zinkevich et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection
- (2011) Tong Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Mitochondrial oxidative stress mediates induction of autophagy and hypertrophy in angiotensin-II treated mouse hearts
- (2011) Dao-Fu Dai et al. Autophagy
- NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies
- (2011) Alexander Sirker et al. BASIC RESEARCH IN CARDIOLOGY
- Mitochondrial Oxidative Stress Mediates Angiotensin II–Induced Cardiac Hypertrophy and Gαq Overexpression–Induced Heart Failure
- (2011) Dao-Fu Dai et al. CIRCULATION RESEARCH
- Renin angiotensin system and cardiac hypertrophy after sinoaortic denervation in rats
- (2011) Aline Cristina Piratello et al. Clinics
- Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independent
- (2011) Sarah J Watkins et al. HYPERTENSION RESEARCH
- The Angiotensin-(1-7)/Mas Receptor Axis Is Expressed in Sinoatrial Node Cells of Rats
- (2011) Anderson J. Ferreira et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice
- (2011) Arun Prasath Lakshmanan et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Identification and characterization of a functional mitochondrial angiotensin system
- (2011) P. M. Abadir et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondria-produced superoxide mediates angiotensin II-induced inhibition of neuronal potassium current
- (2010) Jing-Xiang Yin et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Angiotensin-(1–7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger
- (2010) Amin Shah et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- MAPK-Activated Protein Kinase-2 in Cardiac Hypertrophy and Cyclooxygenase-2 Regulation in Heart
- (2010) John M. Streicher et al. CIRCULATION RESEARCH
- Angiotensin-Converting Enzyme 2: Central Regulator for Cardiovascular Function
- (2010) Huijing Xia et al. CURRENT HYPERTENSION REPORTS
- Angiotensin II receptors and drug discovery in cardiovascular disease
- (2010) Chiranjib Dasgupta et al. DRUG DISCOVERY TODAY
- The role of inflammatory and fibrogenic pathways in heart failure associated with aging
- (2010) Wei Chen et al. HEART FAILURE REVIEWS
- NADPH oxidases and cardiac remodelling
- (2010) Adam Nabeebaccus et al. HEART FAILURE REVIEWS
- Vascular Relaxation, Antihypertensive Effect, and Cardioprotection of a Novel Peptide Agonist of the Mas Receptor
- (2010) Silvia Quintão Savergnini et al. HYPERTENSION
- Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor κB
- (2010) Franziska Rompe et al. HYPERTENSION
- Lifetime Overproduction of Circulating Angiotensin-(1-7) Attenuates Deoxycorticosterone Acetate-Salt Hypertension-Induced Cardiac Dysfunction and Remodeling
- (2010) Nívia M. Santiago et al. HYPERTENSION
- The angiotensin AT2 receptor in left ventricular hypertrophy
- (2010) U Muscha Steckelings et al. JOURNAL OF HYPERTENSION
- Novel regulators and drug targets of cardiac hypertrophy
- (2010) Piet Finckenberg et al. JOURNAL OF HYPERTENSION
- Targeting the ACE2–Ang-(1–7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure
- (2010) Michikado Iwata et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Atrap Deficiency Increases Arterial Blood Pressure and Plasma Volume
- (2010) M. Oppermann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Multifarious molecular signaling cascades of cardiac hypertrophy: Can the muddy waters be cleared?☆
- (2010) Pitchai Balakumar et al. PHARMACOLOGICAL RESEARCH
- Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
- (2010) Bianca C. Bernardo et al. PHARMACOLOGY & THERAPEUTICS
- TRPC1 Channels Are Critical for Hypertrophic Signaling in the Heart
- (2009) Malini Seth et al. CIRCULATION RESEARCH
- Angiotensin-(1-7) Prevents Cardiomyocyte Pathological Remodeling Through a Nitric Oxide/Guanosine 3′,5′-Cyclic Monophosphate–Dependent Pathway
- (2009) Enéas R.M. Gomes et al. HYPERTENSION
- The angiotensin II type 2 receptor in cardiovascular disease
- (2009) Catherine A Lemarié et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Adapter proteins and promoter regulation of the angiotensin AT2 receptor — implications for cardiac pathophysiology
- (2009) Heiko Funke-Kaiser et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Losartan Decreases p42/44 MAPK Signaling and Preserves LZ+ MYPT1 Expression
- (2009) Erhan Ararat et al. PLoS One
- Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes
- (2008) Xinhua Yan et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Regulation of ACE2 in cardiac myocytes and fibroblasts
- (2008) Patricia E. Gallagher et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization
- (2008) Katy Rivard et al. CARDIOVASCULAR RESEARCH
- Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction
- (2008) Justin F.X. Ainscough et al. CARDIOVASCULAR RESEARCH
- Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart
- (2008) Chantal Mercure et al. CIRCULATION RESEARCH
- Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation
- (2008) Noritaka Yasuda et al. EMBO REPORTS
- Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
- (2008) Robson A. S. Santos et al. EXPERIMENTAL PHYSIOLOGY
- Involvement of Nox2 NADPH Oxidase in Adverse Cardiac Remodeling After Myocardial Infarction
- (2008) Yee H. Looi et al. HYPERTENSION
- Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes
- (2008) Marco F. Dias-Peixoto et al. HYPERTENSION
- Discovery and Validation of Novel Peptide Agonists for G-protein-coupled Receptors
- (2008) Ronen Shemesh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure
- (2008) Slava Epelman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reduced isoproterenol-induced renin-angiotensin changes and extracellular matrix deposition in hearts of TGR(A1–7)3292 rats
- (2008) Ana Paula Nadu et al. Journal of the American Society of Hypertension
- Angiotensin II AT1 receptor constitutive activation: From molecular mechanisms to pathophysiology
- (2008) Christophe Petrel et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Angiotensin II: A hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks
- (2008) K.-D. Schlüter et al. PHARMACOLOGY & THERAPEUTICS
- Molecular Mechanisms of Angiotensin II–Mediated Mitochondrial Dysfunction
- (2007) Abdulrahman K. Doughan et al. CIRCULATION RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now